(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PRESIDIO MEDICAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PRESIDIO MEDICAL

ST13

US500000090879720

Class

10, 42

Filing

90879720

Registration

7689547

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

02/11/2025

Trademark type

Combined

Nice classes

10, 42

Filing date

08/12/2021

Registration date

02/11/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/11/2025

Last transaction

02/11/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/30/2019

First use in commerce

07/30/2019

Drawing code

3

Owner type

03

Owner location

South San Francisco, CA

Examiner

HARPER, HANNAH B

Law office

N90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of stylized butterfly wings in the colors blue and light blue above the stylized words "PRESIDIO" and "MEDICAL" in black font.

Holders and representatives

Holders

Presidio Medical, Inc.

Representatives

Julie T. Vo KNOBBE MARTENS OLSON & BEAR, LLP

Technical classification

Nice Classes

Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Neurostimulators for medical use; neurostimulators in the nature of electronic nerve stimulators for pain reduction purposes; neurostimulator delivering electrical pulses to the nerves interrupting the transmission of pain signals to the brain; Medical devicea rechargeable implantable device that transmits mild electrical pulses for the purpose of modulating nerve activity and/or signals; implantable deviceneurostimulator delivering electrical pulses to the nerves interrupting the transmission of pain signals to the brain and reducing pain; Medical deviceimplantable pulse generator; Medical devicean implantable device consisting of thin wires placed in the epidural space connected to an implantable pulse generator; Neurostimulator and components thereforimplantable pulse generatorsleads used with implantable pulse generators; Spinal cord stimulation device for the purpose of modulating nerve activity and/or signals; Medical leadsimplantable neurological leads for spinal cord stimulation ; implantable deviceneurostimulator delivering electrical pulses causing neural blockade; implantable deviceneurostimulator delivering electrical pulses causing anesthesia; Medical devicean electrical stimulation device for pain control; medical device for use in tissue and neural tissue for modulating neurological signals; electrical neuromodulation therapy device for pain control; Medical device for modulating undesired nerve activity and/or signals; Implantable medical device for modulating nerve activity and/or signals; Implantable device for modulating nerve activity and/or signals; Medical devicesnerve stimulators; Medical devicesneuromodulators

Class 42

Scientific and technological servicesresearch and design in the field of neural stimulation technology; Design and development of surgical and medical apparatus and instruments; Design and development of therapeutic devices; Design and development of pain reduction devices

Publications

History of USPTO decisions and trademark events.

39 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/11/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/22/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/22/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/26/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/23/2024

IUAF

USE AMENDMENT FILED

10/10/2024

EISU

TEAS STATEMENT OF USE RECEIVED

10/10/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/05/2024

EX1G

SOU EXTENSION 1 GRANTED

09/05/2024

EXT1

SOU EXTENSION 1 FILED

09/05/2024

EEXT

SOU TEAS EXTENSION RECEIVED

09/04/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/05/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

02/20/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/20/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/20/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/09/2024

PUBO

PUBLISHED FOR OPPOSITION

01/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/20/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/30/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/29/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/28/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/28/2023

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

03/28/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

03/28/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/29/2022

GNRT

NON-FINAL ACTION E-MAILED

12/29/2022

CNRT

NON-FINAL ACTION WRITTEN

12/29/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/16/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/15/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/15/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/16/2022

GNRT

NON-FINAL ACTION E-MAILED

05/16/2022

CNRT

NON-FINAL ACTION WRITTEN

05/16/2022

DOCK

ASSIGNED TO EXAMINER

05/10/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/05/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/04/2021

NWAP

NEW APPLICATION ENTERED

08/16/2021

Continuous trademark protection

Get notified about every new filing that threatens PRESIDIO MEDICAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.